Back to search

Ipsen Bioinnovation Limited

05480340

active
Private Limited Company
england wales
Companies House
Health Score
65 / 100

Some Concerns

25/30
Filing
0/30
Financial
40/40
Risk

No risk factors detected.

Details

5TH FLOOR THE POINT, LONDON, W2 1AF
Incorporated 14/06/2005

Compliance

Last accounts

31/12/2024

full

Next accounts due

30/09/2026

On track

Confirmation statement

Last: 03/10/2025

Due 17/10/2026

On track

Industry

72110
Research and experimental development on biotechnology

Officers

Dr John Andrew Chaddock

director · Since 31/03/2015

MANAGER

BRITISH · UNITED KINGDOM · Age 57

Also on 2 other boards

Alexandre Visciglio

director · Since 28/05/2021

VP FINANCE IPSEN

FRENCH · FRANCE · Age 47

Also on 6 other boards

Lynne Elizabeth Duncan Millar-Kelly

secretary · Since 05/04/2022

Also on 7 other boards

Lynne Elizabeth Duncan Millar-Kelly

director · Since 05/04/2022

SOLICITOR

BRITISH · UNITED KINGDOM · Age 42

Also on 7 other boards

Persons with Significant Control

Ipsen Developments Limited

75–100% shares
75–100% votes
Appoint directors

5th Floor The Point, 37 North Wharf Road, London, W2 1AF

Reg: 03200696 · Companies House · Limited By Shares

Notified 06/04/2016